Introduction
============

The International Study of Asthma and Allergies in Childhood (ISAAC) studies have shown that childhood asthma defined by the presence of recent wheeze is extremely common in many Latin America countries, where the prevalence is as high as in industrialized countries such as UK and US [@b1]. In addition, asthma prevalence is consistently higher in poor populations in urban areas in Latin America [@b2], [@b3] compared with rural areas [@b4], [@b5]. Possible explanations for these findings include differences in environmental exposures associated with urbanization and the acquisition of a 'modern' lifestyle [@b1].

Asthma and atopic diseases show large differences by age in incidence, prevalence and severity [@b6]. Asthma starts during the first years of life [@b7], while the incidence of hay fever generally peaks around school age and adolescence in industrialized countries [@b8]. Sensitization to aeroallergens increases during childhood and adolescence, reaching a peak in the third decade of life [@b9], [@b10]. A more persistent phenotype of asthma has been associated with atopy in late childhood and early adolescence that may continue into adulthood, while early onset asthma in the absence of atopy may be more likely to resolve [@b6], [@b7]. Environmental triggers of atopic diseases may mediate their effects during discrete time windows such as the first 2 years of life and exposure to these triggers may vary by age resulting in time and age-dependent changes in disease incidence [@b11], [@b12]. Thus, the relationship between asthma and atopy may differ between childhood and adolescence being associated with age-specific differences in environmental exposures and the hormonal changes of puberty [@b11].

Atopy can be measured either by the presence of skin prick test (SPT) reactivity or allergen-specific IgE (asIgE) in serum to common aeroallergens [@b13]. SPT is often preferred in large epidemiological studies because it is easily performed, provides an immediate result, and is commonly used to validate *in vitro* tests for specific IgE [@b13]. However, the results of SPT and asIgE are strongly dissociated in some populations particularly those living in developing countries, where a significant proportion of those with asIgE do not have SPT to the same aeroallergens [@b14]--[@b17]. This observation has been attributed to a down-regulation of allergic effector responses associated with environmental exposures such as infections with helminth parasites [@b1].

The link between asthma and atopic sensitization increases with economic development [@b14]. In the ISAAC phase II study, the population fraction of asthma attributable (PAF) to atopy measured by SPT was 41% in 'affluent' countries but only 20% in 'non-affluent' countries in children aged 8--12 years [@b14]. Similar results were obtained when the presence of specific IgE to common aeroallergens (asIgE) was used to define atopy (45.6% vs. 18.3% respectively) [@b14] Moreover, in the two Latin American study centres included in the ISAAC Phase II study (Pichincha Province, Ecuador and Uruguaiana, Brazil), only 11% of asthma was attributable to SPT [@b14], while a study of children of the same age living in rural Esmeraldas Province in Ecuador showed that only 2.4% of asthma was attributable to SPT [@b18]. The weak associations between asthma and atopy in such populations could be explained by the attenuation of atopy or Th2-mediated allergic responses by environmental factors including chronic helminth infections [@b19], [@b20].

To investigate the effects of geohelminth infections and age on atopy, wheeze, and the association between atopy and wheeze, we conducted a case-control study of recent wheeze in school-age children and adolescents living in a rural area of tropical Ecuador.

Methods
=======

Study area and population
-------------------------

The study was conducted among school children and adolescents in rural Afro-Ecuadorian communities in the districts of Eloy Alfaro and San Lorenzo, in Esmeraldas province, Northeastern Ecuador. The characteristics of the study area and population have been described in detail elsewhere [@b21].

Study design
------------

Between March 2005 and May 2007, a cross-sectional survey was conducted among 3960 school children between 6 and 16 years of age [@b18]. Within this study population, a nested case-control study was performed between November 2007 and March 2009, with wheeze cases selected from the population based on the presence of recent wheeze and controls as a random sample of those without symptoms. Individuals considered eligible to be cases were those with a positive (parental) response to the question, 'Has your child had wheeze in the chest in the last 12 months?' ('El niño(a) ha tenido silbido al pecho en los ultimos 12 meses?'), in the cross-sectional survey and eligible controls were those individuals with a negative response to the question, 'Has your child ever had wheeze in the chest? (Alguna vez en la vida, el niño(a) tuvo silbido al pecho (en cualquier epoca del pasado?)'. At the time of selection of cases and controls, a brief screening questionnaire was administered again to parents. Cases were those children for whom a second positive parental response was obtained to the first question. Four controls for each case were selected from random lists generated using Stata 9 software (Statacorp, College Station, TX, USA) and were eligible if a second negative response was obtained to the second question. Individuals with inconsistent responses for the two questions in the two questionnaires were excluded. The time between the cross-sectional and screening questionnaires was approximately 2 years.

Sample size and study power
---------------------------

A pilot study estimated the prevalence of wheeze within the previous 12 months and SPT in rural area as being 7.3% and 13.5% respectively. We estimated that a sample of 4000 children in the rural area would be needed to obtain 292 wheeze cases or 200 cases with losses of 30% and 800 controls (case-control ratio 1 : 4) to detect an effect on wheeze of OR \< 0.6 for common exposures (40--60% prevalence -- e.g. geohelminth infections and household pets), and OR \< 0.4 for rare exposures (10% -- e.g. family history of allergic disease) with a study power of 80% and *P* \< 0.05 [@b21].

Questionnaire
-------------

A questionnaire was administered to the child\'s parent or guardian in the presence of the child that included the core allergy questions of the ISAAC phase II study [@b22] and supplementary questions, including a detailed history of asthma, rhinitis and eczema symptoms, the management of asthma and potential risk factors [@b21], [@b22].

IgE measurements
----------------

Blood samples (7 mL) were collected by venipuncture from participants, centrifuged and plasma was stored at -- 20°C until testing. Total IgE and IgE antibodies specific for *Dermatophagoides pteronyssinus, Periplaneta americana* (American cockroach) and *Ascaris lumbricoides* were measured using the Pharmacia CAP system (Phadia AB, Uppsala, Sweden) according to the manufacturer\'s instructions. Measurements of asIgE were restricted to *D. pteronyssinus* and *P. americana*. We analysed asIgE in three ways: (1) asIgE level: the highest concentration of asIgE observed for either mite or cockroach; (2) asIgE category: the highest concentration of asIgE observed for either mite or cockroach within the following ranges, \< 0.70, ≥ 0.70--3.49, and ≥ 3.5 kU/L; (3) asIgE positivity: having any asIgE ≥ 0.70 kU/L. Levels of total IgE were log~e~-transformed and expressed as geometric means.

Allergen skin prick testing
---------------------------

Allergic sensitization was measured by skin prick testing with seven allergen extracts (Greer laboratories, Lenoir, NC, USA): *D. pteronyssinus/farinae* mix, American cockroach (*P. americana*), *Alternaria tenuis*, cat dog, '9 southern grass mix' and 'New stock fungi mix', positive histamine and negative saline controls. A positive reaction was defined as a mean weal diameter at least 3 mm greater than the saline control 15 min after pricking the allergen onto the volar side of the forearm using ALK lancets (ALK, Hungerford, UK). For the purposes of analysis, only those children with positive SPTs to cockroach and mite were considered to be SPT positive.

Stool examinations
------------------

Single stool samples were collected and analysed for geohelminth eggs and larvae using the modified Kato Katz (quantification of *A. lumbricoides* and *Trichuris trichiura*) and formol-ether concentration (detection of all geohelminths including hookworm and *Strongyloides stercoralis*) methods [@b23]. As stool eggs counts were over-dispersed, they were log~e~-transformed and expressed as geometric means.

Exercise-induced bronchospasm
-----------------------------

Each child underwent a vigorous six-minute free running exercise with spirometry performed before and five minutes after exercise as described previously [@b21]. The highest forced expiratory volume in 1 s (FEV~1~) from five efforts before and after the exercise were used to measure exercise-induced bronchospasm (EIB) as follows: \[(Pre-exercise FEV~1~ − Post-exercise FEV~1~)/(Pre-exercise FEV~1~)\] × 100. For the purposes of this study, EIB was defined as a fall of 10% in FEV~1~ after exercise. The heart rate before and after exercise was recorded as a measure of the intensity of the exercise.

Statistical analysis
--------------------

Differences in the prevalence of asIgE (≥ 0.70 kU/L), SPT and geohelminth infection markers between cases and controls were evaluated using *χ*^2^ or Fisher\'s exact test where appropriate. Population attributable fractions (PAFs) were calculated using the formula P × (OR − 1)/OR where P is the prevalence of SPT or asIgE among children with recent wheeze. We evaluated the effects of age \[childhood (7--11 years) vs. adolescence (12--19 years)\] with the cut-off defined by the median age of 12 years on atopy and wheeze as follows: (1) A Venn diagram was used to display the distribution of asIgE and SPT responses in asthmatic cases and non-asthmatic controls by age group; and (2) the associations of asIgE, SPT and anti-*Ascaris* IgE with wheeze were estimated for each of the two age groups using random effects logistic regression allowing adjustment for clustering. ORs were adjusted for sex, maternal allergic diseases and maternal smoking.

Geohelminth infections or exposures may act as effect modifiers of the associations between markers of atopy and wheeze. The potential effects of markers of geohelminth infection (positive stool samples for *A. lumbricoides* and/or *T. trichiura* and presence of anti-*Ascaris* IgE \[≥ 0.7 kU/L) on the following associations were assessed using random effects logistic regression or logistic regression models with the 'survey' estimation (to take in account the effect of case-control design and two-level data structure) where appropriate: (1) SPT and recent wheeze; (2) asIgE and recent wheeze; and (3) asIgE and SPT. Models were built separately for presence or absence of geohelminth infections in stools and for presence or absence of anti-*Ascaris* IgE. We used hierarchical analyses to explore whether associations between anti-*Ascaris* IgE and wheeze might be explained by asIgE (i.e. by treating asIgE as an intermediate variable in the association between anti-*Ascaris* IgE and wheeze). For this analysis, the ORs for the models that exclude and include asIgE are compared -- if inclusion reduces the OR towards 1 then this suggest that part of the association may be explained by asIgE. In addition, we evaluated the effects of the two geohelminth infection markers on wheeze, asIgE, and SPT and their joint effects through stratification into four groups: (1) no active infection or IgE sensitization to *Ascaris* (geohelminth ova negative and absence of anti-*Ascaris* IgE), (2) active infection without IgE sensitization to *Ascaris* (ova positive and absence of anti-*Ascaris* IgE), (3) no active infection but evidence of IgE sensitization to *Ascaris* (ova negative and presence of anti-*Ascaris* IgE), (4) active infection in the presence of IgE sensitization to *Ascaris* (ova positive and presence of anti-*Ascaris* IgE). Atopic wheeze was defined by wheeze within the previous 12 months in the presence of asIgE (≥ 0.70 kU/L) to either house dust mite and or cockroach. Multivariate multinomial logistic regression was used to estimate the association between the markers of geohelminth infection and wheezing among non-atopic children (by comparing non-atopic wheezers with non-atopic non-wheezers) and for wheezing among atopic children (by comparing atopic wheezers with atopic non-wheezers). All models were adjusted for *a priori* confounders of age, sex, maternal allergic diseases and maternal smoking (for wheeze outcomes only). Analyses stratified by exposure levels for which separate ORs were estimated were adjusted for *a priori* confounders only because of issues of convergence. Overall analyses for study outcome-exposure associations were adjusted for other confounders using a backward stepwise procedure in which individual covariates were kept in the models if they were significant predictors of the outcome (at *P* \< 0.05) or if they altered OR for the outcome by \> 10%. The potential confounders considered were body mass index, day care attendance, household pet exposures, breastfeeding, sedentarism (exercise levels and time spent watching TV), maternal educational level, source of drinking water, excreta disposal and crowding. All analyses were done using STATA, version 10 (Statacorp).

Ethics
------

The study was approved by the ethics committee of the Hospital Pedro Vicente Maldonado, Ecuador (9-12-04), and the study was conducted in accordance with the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from the parent of each child and signed minor assent from the child. The parent or guardian of each child was provided with a copy of all laboratory results, and all children with geohelminth infections were offered appropriate treatment.

Results
=======

Characteristics of study population
-----------------------------------

A total of 839 children (154 cases and 685 controls) were recruited in the case-control study. The data included in the present analysis were from a sample of 379 of these children for whom measurement were done of asIgE, total IgE and anti-*Ascaris* IgE in plasma. This sample included 150 (97.4%) of the 154 asthma cases and a random sample of controls \[229/685 (33.4%)\]. The number of children with complete data for recent wheeze and markers of atopy was 376 (149 cases and 227 controls) and with data for geohelminth infections also was 363 (142 cases and 221 controls). The characteristics of cases and controls are shown in [Table 1](#tbl1){ref-type="table"}. Among infected children, the geometric mean infection intensity for *A. lumbricoides* was 2587 eggs per gram (epg) of feces (range, 70--169, 400) and 785 epg (range, 70--83, 650) for *T. trichiura,* and did not vary between cases and controls. Geometric mean levels of total IgE (668 vs. 427 IU/mL, *P* = 0.002) and specific IgE for *Ascaris* (2.96 vs. 1.45 kU/L, *P* \< 0.0001) and *D. pteronyssinus* (0.72 vs. 0.50 kU/L, *P* = 0.003) were significantly greater in cases than controls, but there were no differences in levels of specific IgE for *P. americana* (0.50 vs. 0.47 kU/L, *P* = 0.41). The PAFs for recent wheeze associated with detectable levels of asIgE and SPT were 10.5% and 10.0%, respectively, while that for anti-*Ascaris* IgE was 45.9%.

###### 

Characteristics of cases and controls

                                              Cases         Controls      *P*-value[\*](#tf1-1){ref-type="table-fn"}
  ------------------------------------------- ------------- ------------- --------------------------------------------
  Age (years)                                                             
  7--10                                       59 (39.6%)    56 (24.7%)    
  11--14                                      70 (47.0%)    110 (48.5%)   
  15--19                                      20 (13.4%)    61 (26.9%)    0.001
  Sex                                                                     
  Male                                        83 (55.7%)    129 (56.8%)   
  Female                                      66 (44.3%)    98 (43.2%)    0.830
  Maternal education level \[5\]                                          
  Complete secondary or higher                14 (9.4%)     16 (7.2%)     
  Complete primary or incomplete secondary    55 (36.9%)    94 (42.3%)    
  Illiterate or incomplete primary            80 (53.7%)    112 (50.5%)   0.506
  Excreta disposal                                                        
  Toilet or latrine                           85 (57.1%)    136 (59.9%)   
  Open field                                  64 (42.9%)    91 (40.1%)    0.581
  Birth order                                                             
  1st--3rd                                    58 (38.9%)    78 (34.4%)    
  ≥ 4th                                       91 (61.1%)    149 (65.6%)   0.368
  Maternal allergic diseases                                              
  No                                          60 (40.3%)    162 (71.4%)   
  Yes                                         89 (59.7%)    65 (28.6%)    \< 0.001
  Maternal smoking                                                        
  No                                          118 (79.2%)   193 (85.0%)   
  Yes                                         31 (20.8%)    34 (15.0%)    0.144
  Skin prick reaction                                                     
  Any allergen (dust mite or cockroach)                                   
   Negative (\< 3 mm)                         120 (80.5%)   198 (87.2%)   
   Positive (≥ 3 mm)                          29 (19.5%)    29 (12.8%)    0.079
  Dust mite                                   21 (14.1%)    18 (7.9%)     0.055
  Cockroach                                   10 (6.7%)     15 (6.6%)     0.969
  Grass mix                                   1 (0.7%)      3 (1.3%)      0.548
  Cat                                         2 (1.3%)      1 (0.4%)      0.336
  Dog                                         1 (0.7%)      0 (0.0%)      0.216
  Fungi                                       0 (0.0%)      0 (0.0%)      
  Alternaria                                  0 (0.0%)      1 (0.4%)      0.417
  Allergen specific IgE (asIgE)                                           
  Any asIgE (dust mite or cockroach)                                      
   Negative (\< 0.70 kU/L)                    100 (67.1%)   171 (75.3%)   
   Positive (≥ 0.70 kU/L)                     49 (32.9%)    56 (24.7%)    0.082
  Any asIgE levels (dust mite or cockroach)                               
  \< 0.70 kU/L                                100 (67.1%)   171 (76.2%)   
  0.70--3.49 kU/L                             25 (16.8%)    42 (18.5%)    
  ≥ 3.50 kU/L                                 24 (16.1%)    14 (6.2%)     0.007
  IgE to dust mite (≥ 0.70 kU/L)              34 (22.8%)    38 (16.7%)    0.143
  IgE to cockroach (≥ 0.70 kU/L)              26 (17.5%)    31 (13.7%)    0.316
  Anti-*Ascaris* IgE (≥ 0.70 kU/L)            115 (77.2%)   130 (57.3%)   \< 0.001
  Exercise-Induced Bronchospasm \[14\]                                    
  No                                          121 (85.8%)   213 (96.4%)   
  Yes                                         20 (14.2%)    8 (3.6%)      \< 0.001
  Geohelminth infections \[13\]                                           
  Any geohelminth                             64 (74.4%)    65 (73.0%)    0.835
  *Ascaris lumbricoides*                      65 (45.8%)    105 (47.5%)   0.746
  *Trichuris trichiura*                       82 (57.8%)    129 (58.4%)   0.906
  Hookworm                                    9 (6.3%)      20 (9.1%)     0.352
  *Strongyloides stercoralis*                 0 (0.0%)      1 (0.5%)      0.422

Comparison of cases and control subjects: X^2^ or Fisher\'s exact test.

Number of missing values are given in parentheses.

Exercise-Induced Bronchospasm: 10% fall in FEV~1~ after exercise.

Effect of age on associations between wheeze and atopy
------------------------------------------------------

The proportional Venn diagram ([Figure 1](#fig01){ref-type="fig"}) showed that a substantial and similar proportion of children aged 7--11 years with (cases) and without (controls) recent wheeze (69.7% vs. 73.3%, respectively) had no evidence of atopy (as measured using either SPT or asIgE to *D. pteronyssinus* and *P. americana*). Among adolescents aged 12--19 years, 51.7% of cases and 70.1% of controls had no evidence of atopy. The second most frequent category for both cases and controls was asIgE (in the absence of SPT), and this proportion increased with age in cases (i.e. 7--11 years, 15.7% vs. 12--19 years, 21.7%) and controls (7--11 years 13.3% vs. 12--19 years, 17.5%). There was a greater overlap of the two markers of atopy among cases than controls in both age groups. Relatively low concordances were observed between the two markers of atopy in cases and controls (*κ* = 0.423 and 0.363 respectively). Among all children, only 44.9% (22/49) of cases with asIgE had a positive SPT, while 75.9% (22/29) of cases with positive SPT had asIgE. The respective proportions among controls were 35.7% (20/56) and 69.0% (20/29) respectively. The associations between markers of atopy and recent wheeze by age grouping are shown in [Table 2](#tbl2){ref-type="table"}. The prevalence of SPT was associated with an increased risk of wheeze in the older but not in the younger age group (adj. OR 2.99, 95% CI 1.31--6.80, *P* = 0.009 vs. adj. OR 1.20, CI 0.48--2.99, *P* = 0.697). In the case of specific allergens, SPT to *D. pteronyssinus* was significantly associated with wheeze in the older age group (adj. OR 2.76, 95% CI 1.07--7.13, *P* = 0.036), but there was no association between SPT to *P. americana* and wheeze in either age group. An association between wheeze and asIgE was observed in the older age group only among children with high levels of asIgE (≥3.5 kU/L) (adj. OR 3.90, 95% CI 1.39--10.96, *P* = 0.010). For specific allergens, IgE to *D. pteronyssinus* and *P. americana* was not significantly associated with wheeze in either age group. There was no evidence for a statistically significant interaction between age and atopy on the risk of wheeze (*P*-values for interaction for SPT and asIgE, 0.368 and 0.234 respectively). The presence of specific IgE to *A. lumbricoides* was significantly associated with wheeze in both age groups (7--11 years, adj. OR 2.06, 95% CI 1.05--4.03, *P* = 0.035 vs. 12--19 years, adj. OR 3.00, 95% CI 1.37--6.56, *P* = 0.006). There was no difference in the prevalence of *A.lumbricoides* or other geohelminths between cases and controls in either age group (data not shown).

###### 

Associations of recent wheeze (cases) with allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cockroach and anti-*Ascaris* IgE

                                     7--11 years (*n* = 179)   12--19 years (*n* = 197)   Total (*N* = 376)                                                                                 
  ---------------------------------- ------------------------- -------------------------- ------------------- ----- ----------- -------------------- ----- ------------ ------------------- -------
  Any asIgE levels (kU/L)                                                                                                                                                                   
  \< 0.70                            134                       64 (48.1)                  1.0                 137   36 (26.3)   1.0                  273   100 (36.6)   1.0                 
  0.70--3.49                         26                        12 (46.2)                  0.75 (0.30--1.86)   41    13 (31.7)   1.22 (0.55--2.72)    65    25 (38.5)    1.00 (0.54--1.81)   0.80
                                                                                          *P* = 0.534                           *P* = 0.620                             0.979               
  ≥ 3.50                             19                        13 (68.4)                  1.92 (0.64--5.75)   19    11 (57.9)   3.80 (1.35--10.76)   38    24 (63.2)    2.84 (1.34--6.06)   10.44
                                                                                          *P* = 0.242                           *P* = 0.011                             0.007               
  Any asIgE (≥ 0.70 kU/L)                                                                                                                                                                   
  Negative                           134                       64 (47.8)                  1.0                 137   36 (26.3)   1.0                  271   100 (36.9)   1.0                 
  Positive                           45                        25 (55.6)                  1.10 (0.53--2.29)   60    24 (40.0)   1.79 (0.91--3.52)    105   49 (46.7)    1.47 (0.89--2.41)   10.52
                                                                                          *P* = 0.805                           *P* = 0.089                             *P* = 0.131         
  asIgE to HDM (≥ 0.70 kU/L)                                                                                                                                                                
  Negative                           152                       73 (48.0)                  1.0                 152   42 (27.6)   1.0                  304   115 (37.8)   1.0                 
  Positive                           27                        16 (59.3)                  1.38 (0.56--3.39)   45    18 (40.0)   1.77 (0.86--3.68)    72    34 (47.2)    1.64 (0.93--2.89)   8.91
                                                                                          *P* = 0.488                           *P*=0.123                               *P* = 0.087         
  asIgE to cockroach (≥ 0.70 kU/L)                                                                                                                                                          
  Negative                           151                       74 (49.0)                  1.0                 168   49 (29.2)   1.0                  319   123 (38.6)   1.0                 
  Positive                           28                        15 (53.6)                  0.97 (0.41--2.31)   29    11 (37.9)   1.46 (0.61--3.47)    17    26 (45.6)    1.20 (0.65--2.23)   2.91
                                                                                          *P* = 0.949                           *P* = 0.396                             *P* = 0.558         
  Anti-*Ascaris* IgE (≥ 0.70 kU/L)                                                                                                                                                          
  Negative                           67                        23 (34.3)                  1.0                 64    11 (17.2)   1.0                  131   34 (26.0)    1.0                 
  Positive                           112                       66 (58.9)                  2.06 (1.05--4.03)   133   49 (36.8)   3.00 (1.37--6.56)    245   115 (46.9)   2.47 (1.50--4.07)   45.93
                                                                                          *P* = 0.035                           *P* = 0.006                             *P* \< 0.001        
  Any SPT (≥ 3 mm)                                                                                                                                                                          
  Negative                           154                       76 (49.4)                  1.0                 164   44 (26.8)   1.0                  318   120 (37.7)   1.0                 
  Positive                           25                        13 (52.0)                  1.20 (0.48--2.99)   33    16 (48.5)   2.99 (1.31--6.80)    58    29 (50.0)    2.05 (1.11--3.78)   9.97
                                                                                          *P* = 0.697                           *P* = 0.009                             *P* = 0.022         
  SPT to HDM (≥ 3 mm)                                                                                                                                                                       
  Negative                           162                       79 (48.8)                  1.0                 175   49 (28.0)   1.0                  337   128 (38.0)   1.0                 
  Positive                           17                        10 (58.8)                  1.40 (0.47--4.21)   22    11 (50.0)   2.76 (1.07--7.13)    39    21 (53.9)    2.15 (1.04--4.42)   7.54
                                                                                          *P* = 0.545                           *P* = 0.036                             *P* = 0.038         
  SPT to cockroach (≥ 3 mm)                                                                                                                                                                 
  Negative                           169                       85 (50.3)                  1.0                 182   54 (29.7)   1.0                  351   139 (39.6)   1.0                 
  Positive                           10                        4 (40.0)                   0.80 (0.19--3.33)   15    6 (40.0)    1.91 (0.61--6.03)    25    10 (40.0)    1.37 (0.56--3.34)   1.81
                                                                                          *P* = 0.763                           *P* = 0.269                             *P* = 0.494         

OR estimated by random effects logistic regression model and adjusted by sex, maternal allergic diseases, maternal smoking.

OR estimated by random effects logistic regression model and adjusted by age, sex, maternal allergic diseases, maternal smoking.

Any SPT/Any asIgE -- SPT or specific IgE for either mite or cockroach.

![Proportional Venn Diagrams for the overlap between allergen specific IgE (asIgE ≥ 0.70 kU/L) and allergen skin prick test (SPT) responses in cases and controls by age grouping (*N* = 376). Within each diagram, the circles show the proportions of cases or controls with asIgE or SPT responses or where the circles overlap, the proportions with both atopic markers. Areas within the diagram but outside the circles represent the proportions with no positive atopic marker (no atopy) for either cases (wheeze) or controls (no wheeze).](cea0043-0060-f1){#fig01}

Effects of geohelminth infections on associations between atopy and wheeze
--------------------------------------------------------------------------

Geohelminth infections or exposures may act as effect modifiers of the associations between markers of atopy and wheeze. The presence of active geohelminth infections appeared to reduce the size of the ORs for the associations between SPT and wheeze ([Table 3](#tbl3){ref-type="table"}; No geohelminths \[negative\], adj. OR 3.52, 95% CI 1.05--11.79, *P* = 0.041 vs. any geohelminth \[positive\] adj. OR 1.59, 95% 0.72--3.54, *P* = 0.253), although there was not statistical evidence for interaction (*P* = 0.366). There was some limited evidence also that children with active geohelminth infections had a weaker association between asIgE and wheeze ([Table 3](#tbl3){ref-type="table"}). In the case of anti-*Ascaris* IgE, the association between SPT and wheeze did not appear to be affected ([Table 3](#tbl3){ref-type="table"}), but there was some evidence that children without anti-*Ascaris* IgE had a stronger association between asIgE and wheeze compared with those with anti- *Ascaris* IgE. Inclusion of anti-*Ascaris* IgE, but not active geohelminth infections, as a variable in the model for the association between asIgE and wheeze (data no shown), resulted in a decrease in OR (without anti-*Ascaris* IgE, adj. OR 1.47, 95% IC 0.89--2.41, *P* = 0.131 vs. with anti-*Ascaris* IgE, adj. OR 1.18, 95% CI 0.70--1.98, *P* = 0.530) suggesting that part of the association may be explained by anti-*Ascaris* IgE.

###### 

Associations of wheeze with allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cockroach stratified by presence of the geohelminth infection markers, *Ascaris lumbricoides* and/or *Trichuris trichiura* or anti-*Ascaris* IgE

                            *A. lumbricoides* and or *T. trichiura* infection                                                                    
  ------------------------- --------------------------------------------------- -------------------- ------- --------------- ------------------- -------
  Any asIgE levels (kU/L)                                                                                                                        
  \< 0.70                   23 (31.9)/72                                        1.0                          73 (38.6)/189   1.0                 
  ≥ 0.70                    19 (47.5)/40                                        2.23 (0.81--6.16)    0.123   27 (43.6)/62    1.05 (0.56--1.98)   0.870
  Any SPT                                                                                                                                        
  Negative                  29 (33.3)/87                                        1.0                          85 (38.8)/219   1.0                 
  Positive                  13 (52.0)/25                                        3.52 (1.05--11.79)   0.041   15 (46.9)/32    1.59 (0.72--3.54)   0.253

                            Anti-*Ascaris* IgE (kU/L)                                                                   
  ------------------------- --------------------------- ------------------- ------- --------------- ------------------- -------
  Any asIgE levels (kU/L)                                                                                               
  \< 0.70                   28 (24.1)/116               1.0                         72 (46.5)/155   1.0                 
  ≥ 0.70                    6 (40.0)/15                 2.88 (0.84-9.88)    0.093   43 (47.8)/90    1.00 (0.56-1.76)    0.993
  Any SPT                                                                                                               
  Negative                  28 (24.6)/114               1.0                         92 (45.1)/204   1.0                 
  Positive                  6 (35.3)/17                 2.53 (0.77--8.27)   0.125   23 (56.1)/41    1.96 (0.93--4.12)   0.075

ORs estimated by random effects logistic regression and adjusted by age, sex, maternal smoking and maternal allergic diseases.

Effect of geohelminth infections on associations between asIgE and SPT
----------------------------------------------------------------------

Geohelminth infections or IgE sensitization to *A. lumbricoides* could modify the association between asIgE and SPT. A significantly weaker association between asIgE and SPT was observed among children with anti-*Ascaris* IgE compared with those without (adj. OR 8.80, 95% CI 2.64--29.28, *P* = 0.001 vs. adj. OR 44.19, 95% CI 3.40--373.80, *P* = 0.005; test for interaction, *P* = 0.016), but the presence of active geohelminth infections did not markedly alter this association ([Table 4](#tbl4){ref-type="table"}). The association between asIgE and SPT was altered little by controlling for the effects of anti-*Ascaris* IgE (without anti-*Ascaris* IgE, adj. OR 11.03, 95% CI 4.42--27.53, *P* \< 0.001 vs. with adj. OR 13.83, 95% CI 4.85--39.42, *P* \< 0.001), suggesting that cross-reactivity between asIgE and anti-*Ascaris* IgE is an unlikely explanation for the dissociation between the results of asIgE and SPT.

###### 

Association between allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cockroach stratified by presence and absence of *A. lumbricoides* and*/*or *T. trichiura* infection or anti-*Ascaris* IgE

                            *A. lumbricoides* and or *T. trichiura* infection                                                                       
  ------------------------- --------------------------------------------------- --------------------- --------- -------------- -------------------- -------
  Any asIgE levels (kU/L)                                                                                                                           
  \< 0.70                   6 (8.33)/72                                         1.0                             10 (5.3)/189   1.0                  
  ≥ 0.70                    15 (47.5)/40                                        14.04 (3.44--57.29)   \<0.001   22 (35.5)/62   9.16 (2.39--35.07)   0.002

                     Anti-*Ascaris* IgE (kU/L)                                                                      
  ------------------ --------------------------- ---------------------- ------- -------------- -------------------- -------
  Any asIgE (kU/L)                                                                                                  
  \< 0.70            6 (5.2)/116                 1.0                            10 (6.5)/155   1.0                  
  ≥ 0.70             11 (73.3)/15                44.19 (3.40--373.80)   0.005   31 (34.4)/90   8.80 (2.64--29.28)   0.001

ORs estimated by logistic regression model with survey estimation and adjusted by age, sex and maternal allergic diseases.

Associations between markers of geohelminth infection and atopy/wheeze
----------------------------------------------------------------------

The associations between geohelminth infection markers and study outcomes are shown in [Table 5](#tbl5){ref-type="table"}. Children with anti-*Ascaris* IgE had a higher prevalence of recent wheeze (adj. OR 2.24, 95% CI 1.33--3.78, *P* = 0.003) and asIgE (adj. OR 5.34, 95% CI 2.49--11.45, *P* \< 0.001). The effect on wheeze was affected little by adjustment for asIgE (inclusion of asIgE in model, adj. OR 2.13, 95% CI 1.24--3.66, *P* = 0.006), suggesting that the effects of anti-*Ascaris* IgE on wheeze cannot be explained by asIgE. Although anti-*Ascaris* IgE was positively associated with EIB, this effect was not significant (adj. OR 5.03, 95% CI 0.22--112.90, *P* = 0.305). The presence of anti-*Ascaris* IgE was strongly associated with atopic wheeze (i.e. defined by recent wheeze with asIgE ≥ 0.70 kU/L) (adj. OR 6.98, 95% CI 2.69--18.08, *P* = 0.001) and also significantly associated with non-atopic wheeze (adj. OR 2.67, 95% CI 1.48--4.81, *P* \< 0.001). On the other hand, active infections with any geohelminth or *A. lumbricoides* alone were not associated with wheeze or atopy, but children with *T. trichiura* infections had a significantly reduced prevalence of atopic wheeze (adj. OR 0.47, 95% CI 0.22--0.98, *P* = 0.043), an observation that was reflected in a strong inverse association between *T. trichiura* infection and the prevalence of SPT (adj. OR 0.42, 95% CI 0.17--0.99, *P* = 0.053).

###### 

Associations of markers of geohelminth infection with wheeze, and presence of skin prick test reactivity (SPT) and allergen specific IgE (asIgE) to house dust mite and cockroach

                                       Wheeze OR (CI 95%)      SPT (≥ 3 mm) OR (CI 95%)   asIgE OR (CI 95%)        Atopic wheeze OR (CI 95%)   Non-atopic wheeze OR (CI 95%)
  ------------------------------------ ----------------------- -------------------------- ------------------------ --------------------------- -------------------------------
  Anti-*Ascaris* IgE                                                                                                                           
   \< 0.70 kU/L                        1.0                     1.0                        1.0                      1.0                         1.0
   ≥ 0.70 kU/L                         **2.24 (1.33--3.78)**   1.15 (0.45--2.95)          **5.34 (2.49--11.45)**   **6.98 (2.69--18.08)**      **2.67 (1.48--4.81)**
                                       ***P***=**0.003**       *P* = 0.761                ***P*** **\< 0.001**     *P* = 0.001                 ***P*****\< 0.001**
  *A. lumbricoides* infection                                                                                                                  
   Negative                            1.0                     1.0                        1.0                      1.0                         1.0
   Positive                            0.90 (0.55-1.48)        0.82 (0.41--1.64)          0.86 (0.53--1.41)        0.76 (0.37--1.55)           0.99 (0.57--1.73)
                                       *P* = 0.680             *P* = 0.570                *P* = 0.549              *P* = 0.447                 *P* = 0.976
  *T. trchiura* infection                                                                                                                      
   Negative                            1.0                     1.0                        1.0                      1.0                         1.0
   Positive                            0.72 (0.44--1.18)       0.42 (0.17--0.99)          0.78 (0.47--1.28)        **0.47 (0.22--0.98)**       0.82 (0.46--1.47)
                                       *P* = 0.187             *P* = 0.053                *P* = 0.318              *P* = 0.043                 *P* = 0.510
  Geohelminth infections                                                                                                                       
   Negative                            1.0                     1.0                        1.0                      1.0                         1.0
   Positive                            0.94 (0.55--1.62)       0.68 (0.32--1.47)          0.74 (0.44--1.23)        0.49 (0.23--1.04)           1.20 (0.63--2.26)
                                       *P* = 0.828             *P* = 0.327                *P* = 0.238              *P* = 0.064                 *P* = 0.581
  Geohelminth ova/anti-*Ascaris* IgE                                                                                                           
   Ova -/IgE-                          1.0                     1.0                        1.0                      1.0                         1.0
   Ova +/IgE-                          0.80 (0.33--1.91)       0.64 (0.10--3.99)          0.30 (0.04--2.31)        --                          1.02 (0.40--2.61)
                                       *P* = 0.614             *P* = 0.628                *P* = 0.245              --                          *P* = 0.961
   Ova -/ IgE+                         **2.18 (1.08--4.42)**   1.01 (0.40--2.54)          **3.54 (1.48--8.45)**    **4.26 (1.35--13.39)**      **2.58 (1.13--5.91)**
                                       *P* = 0.030             *P* = 0.982                *P* = 0.005              *P* = 0.013                 *P* = 0.025
   Ova +/ IgE+                         **2.03 (1.01--4.05)**   0.94 (0.40--2.19)          **3.36 (1.53--7.38)**    **3.73 (1.20--11.61)**      **2.39 (1.06--5.38)**
                                       *P* = 0.046             *P* = 0.885                *P* = 0.003              *P* = 0.023                 *P* = 0.036

Statistically significant (*P* \< 0.05) ORs are shown in bold. All wheeze outcomes refer to wheeze within the previous 12 months (recent wheeze). Geohelminth ova or infections represent presence of ova of *A. lumbricoides* and/or *T. trichiura*. OR for 4-way analysis of Ova/IgE were adjusted for *a priori* confounders only. ORs for two-level geohelminth exposures were adjusted for the following confounders: wheeze -- age, sex, maternal allergic disease, maternal smoking, maternal education, family income, birth order, excreta disposal, dog inside house currently and recent anthelminthic treatment; atopic markers -- age, sex, maternal education, family income, birth order, excreta disposal and recent anthelminthic treatment. Atopic wheeze was defined as wheeze within the previous 12 months in the presence of ≥ 0.70 kU/L of house dust mite and or cockroach.

To explore the effects of active infections vs. IgE sensitization to *Ascaris* on study outcomes, we stratified the children into four infection groups according to the presence and absence of geohelminth infections and anti-*Ascaris* IgE ([Table 5](#tbl5){ref-type="table"}). The four-group stratification showed significant associations between the presence of anti-*Ascaris* IgE and recent wheeze, the presence of asIgE, and atopic and non-atopic wheeze ([Table 5](#tbl5){ref-type="table"}) that was independent of the presence of geohelminth ova in stool samples. No significant associations with study outcomes were observed among children without anti-*Ascaris* IgE.

Discussion
==========

Childhood asthma has emerged as a major public health problem in many Latin American countries [@b1], although there are marked differences in asthma prevalence and morbidity between and within countries, particularly between urban and rural populations [@b24], [@b25]. The causes of regional differences in asthma prevalence are likely to reflect distinct patterns of environmental exposures interacting with genetic factors. Atopy is considered an important determinant of the prevalence [@b14] and severity [@b26] of childhood asthma in industrialized countries; however, population-based studies of children and adolescents aged 4--16 years with asthma symptoms [@b18], [@b27], [@b28] and bronchial hyperresponsiveness [@b29] in Latin America have shown only weak associations with atopy. Thus, the factors that modify the association between atopy and asthma and that affect the prevalence of atopy in Latin American populations are of public health relevance.

Over recent years, there has been interest in the role of geohelminth infections in affecting atopy and asthma prevalence although the findings of studies have been inconsistent [@b19]. In the present case-control analysis, we explored the effects of age and geohelminth infections on the association between atopy and recent wheeze in school-age children living in a rural area of Ecuador. Less than a third of children with wheeze had evidence of atopy to the dominant sensitizing allergens in our study population, house dust mite and cockroach, whereas this proportion increased to half among adolescents. Further, the association between atopy and wheeze was stronger in adolescents compared with children. IgE sensitization to *Ascaris* but not active geohelminth infections (measured by the presence of eggs in stool samples) increased the risk of wheeze in children and adolescents independently of asIgE. The fraction of wheeze that was attributable to anti-*Ascaris* IgE in our study population was 45.9%, while the attributable fractions for asIgE and SPT were just 10.5% and 10.0% respectively. These data strongly support an important role for allergic sensitization to *Ascaris* as a risk factor for wheeze.

Asthma during childhood is complex and has different characteristics at different ages, perhaps as a consequence of the influence of environmental exposures, that may vary by age, on underlying genetic susceptibilities [@b30]. Cohort studies have demonstrated that transient wheeze and non-atopic wheeze phenotypes predominate during the first years of life and mid-childhood respectively. Persistent wheeze, more commonly associated with atopy and airways hyperresponsiveness, tends to appear in late childhood and early adolescence and may continue into adulthood [@b7]. In our study population, there was some evidence that the association between wheeze and atopy increased with age. Previous studies in children and adolescents in underprivileged populations in Latin America have shown weak associations between atopy and wheeze/asthma [@b2], [@b18], [@b27], [@b28], while a study in adults [@b31] showed a moderate to high association indicating that the age of the study population could be a possible explanation for differences between studies. Genetic studies have addressed the influence of age on the development of atopy and asthma [@b6], and have identified distinct susceptibility genes that are associated with childhood and adult asthma [@b32], [@b33]. Adolescence is characterized by rapid hormonal, physical and behavioural changes, all of which may affect the natural course of asthma. Sex hormones can alter β2-adrenergic responsiveness [@b34] and female hormones have been shown to increase the production of Th2-like cytokines from peripheral blood mononuclear cells [@b35]. Leptin has been proposed as one of the signals controlling sexual maturation [@b36] and may also be involved in the regulation of respiratory function [@b37]. Exposure to important environmental exposures and the effects of these on asthma phenotypes may vary by age [@b11].

The low PAF values for wheeze with respect to atopy observed here (10.5% for asIgE and 10.0% for SPT) are consistent with the findings of the ISAAC phase II study that estimated PAFs for SPT of only 11% for both South American study centres [@b14]. A possible explanation for the low association between markers of atopy and wheeze is exposure to factors that reduce atopy such as chronic helminth infections that are potent regulators of immune function [@b1], [@b20]. There was some evidence of a weaker association between both markers of atopy and wheeze among children with active geohelminth infections compared with those without (SPT, OR 3.52 vs. OR 1.59; asIgE OR 2.23 vs. OR 1.05 respectively). Geohelminth infections with a pulmonary phase of larval migration of which *A. lumbricoides* is the most relevant -- the others being hookworm and *S. stercoralis* that were of low prevalence in our population -- may, during chronic infections, attenuate the effects of atopy on pulmonary inflammation thus reducing wheeze symptoms. The exclusively enteric parasite, *T. trichiura,* may also have effects on inflammatory responses at distal sites [@b38], [@b39].

In this study, anti-*Ascaris* IgE explained almost half our cases of wheeze and this effect was independent of asIgE, while active geohelminth infections did not appear to affect the prevalence of wheeze. The presence of anti-*Ascaris* IgE has been identified as a risk factor for asthma and wheeze [@b40]--[@b42], and bronchial hyper-reactivity [@b43]--[@b45] in previous studies. A possible explanation could be cross-reactivity between allergens of *A. lumbricoides* and invertebrates such as cockroach and house dust mite. Cross-reactivity would be suggested to be present if the effect of anti-*Ascaris* IgE on wheeze disappeared when controlling for asIgE (i.e. the effect of anti-*Ascaris* IgE on wheeze is considered to be mediated by asIgE). This appeared to be the case in a previous study that demonstrated a strong association between asthma and anti-*Ascaris* IgE in urban Costa Rica where the prevalence of geohelminths was low [@b45]. However, in another study conducted in rural Bangladesh [@b41], anti-*Ascaris* IgE was shown to be a risk factor for wheeze after adjusting for anti-mite IgE in a population with a high prevalence of geohelminths. Similarly in this study, although anti-*Ascaris* IgE was strongly associated with asIgE, controlling for asIgE had no effect on the association between anti-*Ascaris* IgE and wheeze, indicating that the effect of anti-*Ascaris* IgE on wheeze was independent of asIgE.

There are limited data on the association between markers of geohelminth infections and atopic and non-atopic asthma/wheeze. Our data, from an area of high geohelminth prevalence, showed active geohelminth infections were not associated with wheeze, but that anti-*Ascaris* IgE was a significant risk factor for both atopic and non-atopic wheeze. Previous studies conducted in areas of low geohelminth prevalence have shown the presence of anti-*Ascaris* IgE, that may be the only marker indicating the presence of geohelminth infections [@b45], to be associated with atopic [@b40], [@b44], [@b45] and non-atopic wheeze and asthma [@b27], [@b40]. Thus, active infections with *A. lumbricoides* (in low prevalence areas) and the presence of anti-*Ascaris* IgE (irrespective of geohelminth prevalence) may be associated with increased inflammation in the lungs causing wheeze/asthma. The effect of *A. lumbricoides* exposures on wheeze symptoms may vary by the prevalence of infection: in communities with a low prevalence of infection, the presence of active infections with this parasite has been associated with more frequent symptoms of wheeze [@b19], [@b27], [@b46], while in areas of high prevalence active infections do not appear to be associated with the prevalence of wheeze [@b18]. Possible explanations for the association between anti-*Ascaris* IgE and wheeze include: (1) Individuals with an atopic predisposition are more likely to respond to *Ascaris* exposures with an IgE response and are also at increased risk of recent wheeze. In this study, we observed a similar association in atopics and non-atopics although the association was stronger in atopics (2). The presence of anti-*Ascaris* IgE may represent stronger protective immunity to *Ascaris* [@b47]. Such protective immune responses could cause pulmonary inflammation and wheeze when targeted against *Ascaris* larvae migrating through the lungs [@b19]. As protective immunity against ascariasis in humans is not sterile, such an effect would explain why the association between anti-*Ascaris* IgE and wheeze was independent of the presence of eggs in stool samples. (3) The presence of anti-*Ascaris* IgE may be a marker for exposures to closely related zoonotic infections such as *A. suum* and *Toxocara canis* with which *A. lumbricoides* shares extensive immunological cross-reactivity [@b48]. Human infections with *Toxocara* and *A. suum*, causing visceral larva migrans, have been associated with asthma-like symptoms [@b49], [@b50], [@b51]. Overall, our observations point to the importance of the immunological response to *A. lumbricoides* rather than the presence *per se* of geohelminths, as an important determinant of wheeze in our study population.

There are several limitations to this analysis that should be considered. Firstly, we defined atopy to just two dominant aeroallergens, house dust mite and cockroach. In our study population, house dust mite and cockroach are the most important environmental allergens when atopy is measured either by SPT or asIgE. An analysis of SPT responses to seven relevant aeroallergens in the cross-sectional study of 3960 children in which the present case-control analysis was nested showed that only 3.1% of children with negative SPTs to mite and cockroach had positive SPTs to any of the other allergens tested [@b18]. These results are consistent with those of previous studies from school children in Ecuador [@b52], [@b53]. With respect to asIgE, measurements were restricted to *D. pteronyssinus* and *P. americana* based on the findings of previous surveys conducted in similar populations in Ecuador [@b15], [@b54]. A previous analysis of 50 plasma samples from school children living in the study area of specific IgE for *D. pteronyssinus*, *P. americana*, rye grass, cat, and *Aspergillus* showed that none of the children negative for *D. pteronyssinus* and *P. americana* were positive for any of the other allergens (Cooper PJ et al., unpublished data). Similarly, the tropical mite, *Blomia tropicalis*, does not appear to be an important sensitizing mite in our population -- a previous survey in the same population showed a very low prevalence of SPT to this mite (1.2%) and an analysis of mites and mite antigens in dust samples showed that \> 90% of mites were *D. pteronyssinus* and few dust samples had measurable levels of Blo t 5, the dominant *B. tropicalis* allergen (Cooper PJ et al., unpublished data). We can be confident that we correctly identified most children with atopy. We used a higher cut-off of ≥ 0.70 kU/L for positivity of tests for specific IgE rather than the conventional cut-off of ≥ 0.35 kU/L because of the possibility of false-positive reactions at low titre that may be associated with the extensive immunological cross-reactivity between helminth allergens and aeroallergens [@b55], [@b56]. Secondly, we used recent wheeze as a proxy for asthma. Wheeze cases and non-wheeze controls were identified from parental questionnaires based on that used in the ISAAC Phase 2 study [@b22] in which children with wheeze within the previous 12 months were identified and their status was confirmed by repeating the same questions approximately 2 years later. Viral respiratory tract infections (RTIs) are a frequent cause of wheeze and are the major cause of asthma exacerbations in children [@b57], and viral RTIs are likely to be a significant cause of wheeze in our study population. In this study, cases represented persistent wheeze (at least one episode of wheeze in the previous year on two occasions), which may be a better proxy for asthma. EIB was used as a marker of the presence of bronchial hyper-reactivity (BHR) at the time of evaluation. Relatively, few wheeze cases had a positive exercise test (14.2%) suggesting either that wheeze in our population is mild and is not associated with significant BHR or that this test may not be a good measure of BHR in the conditions of high ambient humidity [@b58] present throughout the year in the study area. Thirdly, given the sample size, we had limited power for some of the comparisons done, and cannot exclude the possibility of type 2 statistical errors. However, we were able to detect significant effects for the primary study exposures (age and geohelminth exposures) and thus had sufficient power for these associations. Lack of power may be a particular issue in this study where tests for interaction were done -- only one of the interactions tested was statistically significant. Fourthly, we did not measure acetaminophen use in this study, an exposure that has been suggested recently to have a role in the development of childhood asthma [@b59], and cannot exclude residual confounding by acetaminophen use. Limited access to health care and a lack of community pharmacies in the study area may minimize such bias. Finally, the case-control design of the study limits our ability to infer causality or the direction of effects between presumed exposures and outcomes.

In conclusion, our data from a case-control study of wheezing illness in a rural area of tropical Ecuador has provided evidence that most wheeze was not attributable to atopy to house dust mite and cockroach, although the association between atopy and wheeze did appear to increase with age from childhood to adolescence. We identified the presence of anti-*Ascaris* IgE as an important risk factor for wheeze and this association appeared to be independent of asIgE, and was observed for both atopic and non-atopic wheeze. Active geohelminth infections were not associated with wheeze although there was some evidence that active infections reduced the association between atopy and wheeze. Future studies will be necessary to identify the mechanisms by which anti-*Ascaris* IgE may increase the prevalence of wheeze and could provide novel targets for interventions either for the primary prevention or treatment of asthma in childhood.
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